Filing Details

Accession Number:
0001209191-23-020480
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-22 16:03:15
Reporting Period:
2023-03-20
Accepted Time:
2023-03-22 16:03:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1566044 Vyne Therapeutics Inc. VYNE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1055404 G Patrick Lepore C/O Vyne Therapeutics Inc.
685 Route 202/206, Suite 301A
Bridgewater NJ 08807
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-20 20,000 $2.48 23,472 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $2.464 to $2.5199, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. On February 10, 2023, the Issuer effected a one-for-18 reverse split of its Common Stock. The number of securities reported reflects the reverse split.